OcuTerra Therapeutics
About:
OcuTerra Therapeutics is developing novel eye drop designed to treat diabetic eye disease.
Website: https://www.ocuterratx.com/
Top Investors: Robin Hood Ventures
Description:
OcuTerra Therapeutics, Inc. is developing innovative drugs for ophthalmic diseases for which the current standard of care does not prevent or control the progression of the disease.
Total Funding Amount:
$35M
Headquarters Location:
Boston, Massachusetts, United States
Founded Date:
2011-01-01
Contact Email:
info(AT)ocuterratx.com
Founders:
Takeru Furuya, Tobias Ritter
Number of Employees:
11-50
Last Funding Date:
2024-01-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai